Cargando…

Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome Associated with Deletion of Chromosome 20q

Elliptocytosis is commonly seen as a hereditary condition. We present a case of myelodysplastic syndrome (MDS) del(q20) variant with concomitant acquired elliptocytosis. A 73-year-old male with a history of prostate cancer presented to the hospital for evaluation of bleeding gums. Initial evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manthri, Sukesh, Vasireddy, Naresh K., Bandaru, Sindhura, Pathak, Swati
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816871/ https://www.ncbi.nlm.nih.gov/pubmed/29487753 http://dx.doi.org/10.1155/2018/6819172

Ejemplares similares

Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia
por: Kjelland, Jacob D., et al.
Publicado: (2017)

Goserelin Ovarian Ablation Failure in Premenopausal Women With Breast Cancer
por: Gupta, Aanchal, et al.
Publicado: (2021)

Reticulocytosis As a Whistleblower: A Rare Case of Acquired Elliptocytosis in a Myelodysplastic Syndrome Patient With Trisomy 8
por: Hage-Sleiman, Mehdi, et al.
Publicado: (2021)

Cetuximab-Associated Crescentic Diffuse Proliferative Glomerulonephritis
por: Manthri, Sukesh, et al.
Publicado: (2017)

Empyema Necessitans in the Setting of Methicillin-Susceptible Staphylococcus aureus Causing Pneumonia and Bacteremia
por: Bandaru, Sindhura, et al.
Publicado: (2018)

Acute Pericarditis as a Presentation of Adrenal Insufficiency
por: Manthri, Sukesh, et al.
Publicado: (2018)

Hereditary Elliptocytosis with Pyropoikilocytosis
por: Bayhan, Turan, et al.
Publicado: (2016)

Multiple Endocrine Neoplasia Type 1 (MEN1) Presenting as an Invasive Macroprolactinoma Complicated by Acute Bacterial Meningitis
por: Bandaru, Sindhura, et al.
Publicado: (2021)

Novel Use of Calcimimetic Activity to Diagnose Primary Hyperparathyroidism in a Patient With Persistently Low-Normal Parathyroid Hormone Level
por: Bandaru, Sindhura, et al.
Publicado: (2020)

Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions
por: Aziz, Athar, et al.
Publicado: (2013)

Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical–Biological Entity?
por: Campagna, Alessia, et al.
Publicado: (2022)

PB1912: MYELODYSPLASTIC SYNDROME WITH ISOLATED 5Q DELETION AND ASSOCIATED 5Q DELETION TO 13Q DELETION
por: Bouayed Abdelmoula, N., et al.
Publicado: (2022)

Myelodysplastic Syndrome with 6q Deletion as the Sole Chromosome Abnormality in an Iranian Patient: A Case Report with Review of Literature
por: Ferdowsi, Shirin, et al.
Publicado: (2013)

5q Deletion Myelodysplastic Syndrome in a Young Male Patient
por: Elkattawy, Sherif, et al.
Publicado: (2021)

Durable Hematological and Major Cytogenetic Response in a Patient with Isolated 20q Deletion Myelodysplastic Syndrome Treated with Lenalidomide
por: Jana, Bagi, et al.
Publicado: (2014)

Novel compound heterozygous SPTA1 mutations in a patient with hereditary elliptocytosis
por: Ma, Shiyue, et al.
Publicado: (2018)

Aberrant Membrane Composition and Biophysical Properties Impair Erythrocyte Morphology and Functionality in Elliptocytosis
por: Pollet, Hélène, et al.
Publicado: (2020)

Chromosome 11q13 deletion syndrome
por: Kim, Yu-Seon, et al.
Publicado: (2016)

Spectrin Tunis (Sp alpha (I/78)) in a Korean Family with Hereditary Elliptocytosis
por: Han, Eunhee, et al.
Publicado: (2013)

Analysis of Hereditary Elliptocytosis with Decreased Binding of Eosin-5-maleimide to Red Blood Cells
por: Suemori, Shin-ichiro, et al.
Publicado: (2015)

Part 4: Myelodysplastic syndromes—Treatment of low-risk patients with the 5q deletion
por: Magalhães, Silvia Maria Meira, et al.
Publicado: (2018)

Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q Deletion
por: Feurstein, Simone, et al.
Publicado: (2018)

AMMECR1: a single point mutation causes developmental delay, midface hypoplasia and elliptocytosis
por: Andreoletti, Gaia, et al.
Publicado: (2017)

Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy
por: Prebet, Thomas, et al.
Publicado: (2017)

Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion
por: Velloso, Elvira Deolinda Rodrigues Pereira, et al.
Publicado: (2018)

Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis
por: Wong, Jasmine C, et al.
Publicado: (2015)

Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion
por: Castillo, Martín I., et al.
Publicado: (2023)

Isolated Chromosome 6q27 Terminal Deletion Syndrome
por: Bhatta, Sabita, et al.
Publicado: (2020)

A Case of Refractory Thrombocytopenia with 5q Deletion: Myelodysplastic Syndrome Mimicking Idiopathic Thrombocytopenic Purpura
por: Chang, Jeonghyun, et al.
Publicado: (2014)

Analysis of the efficacy of lenalidomide in patients with intermediate-1 risk myelodysplastic syndrome without 5q deletion
por: YANG, YAN, et al.
Publicado: (2013)

Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy
por: Prebet, Thomas, et al.
Publicado: (2017)

Lenalidomide Plus Decitabine Treatment in a Myelodysplastic Syndrome Patient With Deletion 5q and Excess Blasts
por: Serin, Istemi, et al.
Publicado: (2020)

Pseudogout: An Autoimmune Paraneoplastic Manifestation of Myelodysplastic Syndrome
por: Iqbal, Shumaila M, et al.
Publicado: (2018)

The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q
por: Lee, Dawn, et al.
Publicado: (2018)

Lenalidomide treatment of Japanese patients with myelodysplastic syndromes with 5q deletion: a post-marketing surveillance study
por: Uno, Shuji, et al.
Publicado: (2023)

Inversion of chromosome 7q22 and q36 as a sole abnormality presenting in myelodysplastic syndrome: a case report
por: Kaneko, Hiroto, et al.
Publicado: (2014)

Acquired Myelodysplasia or Myelodysplastic Syndrome: Clearing the Fog
por: Natelson, Ethan A., et al.
Publicado: (2013)

Clinical variability of chromosome 22q11.2 deletion syndrome
por: Boyarchuk, Oksana, et al.
Publicado: (2017)

Dopaminergic neurons in chromosome 22q11.2 deletion syndrome
por: Inoue, Haruhisa
Publicado: (2021)

Deletion mapping of chromosome 16q in hepatocellular carcinoma
por: Piao, Z, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_9iufhvlod5qbmgf33qmemcfnla